Satoshi Yasuda

14PUBLICATIONS
122CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyInnate immunityPredictive and prognostic markersMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 11, 2026
Ablation-Based Salvage Strategy at Disease Progression After Initial Disease Control With Atezolizumab/Bevacizumab in Hepatocellular Carcinoma.

|Feb 22, 2026
Long-Term Mortality Following Hepatitis C Cure in a Real-World Multinational Cohort.

Fanpu Ji, Sally Tran, Hidenori Toyoda

|Jan 29, 2026
Effect of Butyrate-Producing Enterobacteria and Proton Pump Inhibitors on Advanced Hepatocellular Carcinoma Treatment With Durvalumab and Tremelimumab.

Kazuhiro Nouso, Akiko Wakuta, Shohei Shiota

|Dec 02, 2025
Hepatitis B Virus RNA Predicts Hepatocellular Carcinoma Despite Viral Suppression.

Takashi Kumada, Hidenori Toyoda, Satoshi Yasuda

|Nov 11, 2025
Evolution of Hepatocellular Carcinoma Treatment Outcomes Over Two Decades in Japan: Improvements in Early-Stage Viral Disease.

Kazuya Kariyama, Kazuhiro Nouso, Atsushi Hiraoka

|Nov 03, 2025
Usefulness of the Fibrosis-3 index in patients with hepatitis C.

Kazuya Kariyama, Hidenori Toyoda, Takashi Kumada

Pageof 3

Frequent Collaborators

13 joint publications

Hidenori Toyoda

10 joint publications

Kazuhiro Nouso

10 joint publications

Takashi Kumada

9 joint publications

Toshifumi Tada